Necroptosis, necrostatins and tissue injury

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 9, 2011, Pages 1797-1806

  Smith, Christopher C T ^a   Yellon, Derek M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cell death; Necroptosis; Necrostatin; Tissue damage

Indexed keywords

INDOLE DERIVATIVE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE;

ANIMAL; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; AUTOPHAGY; DRUG EFFECT; HUMAN; METABOLISM; NECROSIS; PATHOLOGY;

ANIMALS; APOPTOSIS; AUTOPHAGY; HUMANS; INDOLES; NECROSIS; ORGAN SPECIFICITY; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 80052173847     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01341.x     Document Type: Article

References (78)

1. Degterev A, Yuan J. Expansion and evolution of cell death programmes. Nature Rev Mol Cell Biol. 2008; 9: 378-90.
2. Sun Y, Peng Z-L. Programmed cell death and cancer. Postgrad Med J. 2009; 85: 134-40.
3. Vila M, Przedborski S. Targeting programmed cell death in neurodegenerative disease. Nat Rev Neurosci. 2003; 4: 365-75.
4. Ortone E, Margutti P, Matarrese P, et al. Redox state, cell death and autoimmune diseases. Autoimmunity Rev. 2008; 7: 579-84.
5. Logue SE, Gustafsson ÅB. Ischemia/reperfusion injury at the intersection with cell death. J Mol Cell Cardiol. 2005; 38: 21-33.
6. Kroemer G, Galluzzi L, Vandenabeele P, et al. Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ. 2009; 16: 3-11.
7. Degterev A, Huang Z, Boye M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nature Chem Biol. 2005; 1: 112-9.
8. Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol. 1971; 105: 13-20.
9. Bortner CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol. 2002; 42: 259-81.
10. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239-57.
11. Yang YP, Liang ZQ, Gu ZL, Qin ZH. Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin. 2005; 26: 1421-34.
12. Yorimitsu T, Klionsky D. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005; 12: 1542-52.
13. Kunz JB, Schwarz H, Mayer A. Determination of four sequential stages during microautophagyin vitro. J Biol Chem. 2004; 279: 9987-96.
14. Dice JF. Chaperone-mediated autophagy. Autophagy. 2007; 3: 295-9.
15. Klionsky D, Ohsumi Y. Vacuolar import of proteins and organelles from the cytoplasm. Annu Rev Cell Dev Biol. 1999; 15: 1-32.
16. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004; 6: 463-77.
17. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest. 2005; 115: 2679-88.
18. Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging and pathology. Cardovasc Res. 2005; 68: 355-65.
19. Nishida K, Kyoi S, Yamaguchi O, et al. The role of autophagy in the heart. Cell Death Differ. 2009; 16: 31-8.
20. Gustafson ÅB, Gottlieb RA. Recycle or die: the role of autophagy in cardioprotection. J Mol Cell Cardiol. 2008; 44: 654-61.
21. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132: 27-42.
22. Ciechanover A, Schwartz AL. The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochim Biophys Acta. 2004; 1695: 3-17.
23. Wójcik C. Regulation of apoptosis by the ubiquitin and proteasomal pathway. J Cell Mol Med. 2002; 6: 25-48.
24. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005; 122: 927-39.
25. Yousefi S, Perozzo R, Schmid I, et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nature Cell Biol. 2006; 8: 1124-32.
26. Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 1999; 6: 508-15.
27. Festjens N, Vanden Berghe T, Vandenabeele P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta. 2006; 1757: 1371-87.
28. Goldstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci. 2007; 32: 37-43.
29. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nature Rev Drug Discovery. 2005; 4: 421-40.
30. Oei SL, Keil C, Ziegler M. Poly(ADP-ribosylation) and genomic stability. Biochem Cell Biol. 2005; 83: 263-9.
31. Andrabi SA, Kim NS, Yu S-W, et al. Poly (ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci USA. 2006; 103: 18308-13.
32. Yu SW, Andrabi SA, Wang H, et al. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci USA. 2006; 103: 18314-9.
33. Xu Y, Huang S, Liu Z-G, Han J. Poly(ADP-ribose) polymerase-1 signalling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem. 2006; 281: 8788-95.
34. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell. 2008; 135: 1161-3.
35. Formigli L, Papucci L, Tani A, et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol. 2000; 182: 41-9.
36. Wu YT, Tan HL, Huang Q, et al. Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy. 2008; 16: 457-66.
37. Vanden Berghe T, Vanlangenakker N, Parthoens E, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ. 2010; 17: 922-30.
38. Bonapace L, Bornhauser BC, Schmitz M, et al. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Inv. 2010; 120: 1310-23.
39. Teng X, Degterev A, Jagtap P, et al. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett. 2005; 15: 5039-44.
40. Jagtap PG, Degterev A, Choi S, et al. Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem. 2007, 50: 1886-95.
41. Wang K, Li J, Degterev A, et al. Structure-activity relationship analysis of a novel necroptosis inhibitor, necrostatin-5. Bioorg Med Chem Lett. 2007; 17: 1455-65.
42. Vandenabeele P, Declercq W, Vanden Berghe T. Necrotic cell death and 'necrostatins': now we can control cellular explosion. Trends Biochem Sci. 2008; 33: 352-5.
43. Bao L, Li Y, Deng S-X, et al. Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages. J Biol Chem. 2006; 281: 33635-49.
44. Han W, Li L, Qiu S, et al. Shikonin circumvents cancer drug resistance by induction of necroptotic death. Mol Cancer Ther. 2007; 6: 1641-9.
45. Han W, Xie J, Li L, et al. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis. 2009; 14: 674-86.
46. Chua CC, Chua K-W, Gao J, et al. Necroptosis is involved in cardiac cell death induced by chemical ischemia. FASEB J. 2008; 22: 1238.24.
47. Hsu T-S, Yang P-M, Tsai J-S, Lin L-Y. Attenuation of cadmium-induced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Toxicol Appl Pharmacol. 2009; 235: 153-62.
48. 2+ -dependent necrotic cell death through calpain-t riggered mitochondrial depolarization and reactive oxygen species-mediated inhibition of nuclear factor-kappaB activity. Chem Res Toxicol. 2007; 20: 406-15.
49. Krumschnabel G, Ebner HL, Hess MW, Villunger A. Apoptosis and necroptosis are induced in rainbow trout cell lines exposed to cadmium. Aquatic Toxicol. 2010; 99: 73-85.
50. Xu X, Chua CC, Kong J, et al. Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem. 2007; 103: 2004-14.
51. Laird MD, Wakade C, Alleyne CH, Dhandapani KM. Hemin-induced necroptosis involves glutathione depletion in mouse astrocytes. Free Radical Biol Med. 2008; 45: 1103-14.
52. Li Y, Yang X, Ma C, et al. Necroptosis contributes to the NMDA-induced excitotoxicity in rat's cultured cortical neurons. Neurosci Lett. 2008; 447: 120-3.
53. Zhang QL, Niu Q, Ji XL, et al. Is necroptosis a death pathway in aluminium-induced neuroblastoma cell demise? Int J Immunopathol Pharmacol. 2008; 21: 787-96.
54. Hitomi J, Christofferson DE, Ng A, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 2008; 135: 1311-23.
55. Kim JW, Won J, Sohn S, Joe CO. DNA-binding activity of the N-terminal cleavage product of poly(ADP-ribose) polymerase is required for UV mediated apoptosis. J Cell Sci. 2000; 113: 955-61.
56. Zong WX, Ditsworth D, Bauer DE, et al. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 2004; 18: 1272-82.
57. Xu X, Chua CC, Zhang M, et al. The role of PARP activation in glutamate-induced necroptosis in HT-22 cells. Brain Res. 2010; 1343: 206-12.
58. Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci. 2005; 30: 151-9.
59. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differen. 2007; 14: 400-10.
60. Declerq W, Vanden Berghe T, Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell. 2009; 138: 229-32.
61. Zhang D, Lin J, Han J. Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol. 2010; 7: 243-9.
62. Kelliher MA, Grimm S, Ishida Y, et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity. 1998; 8: 297-303.
63. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000; 1: 489-95.
64. Zheng L, Bidere N, Staudt D, et al. Competitive control of independent programs of tumour necrosis factor receptor-induced cell death by TRADD and RIP1. Mol Cell Biol. 2006; 26: 3505-13.
65. Degterev A, Hitomi J, Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008; 4: 313-21.
66. Kim S, Dayani L, Rosenberg PA, Jianrong L. RIP1 kinase mediates arachidonic acid-induced oxidative death of oligodendrocyte precursors. Int J Physiol Pathophyiol Pharmacol. 2010; 2: 137-47.
67. Cho YS, Challa S, Moquin D, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009; 137: 1112-23.
68. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T, The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal. 2010; 3: 1-8.
69. Northington FJ, Chavez-Valdez R, Graham EM, et al. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab. 2011; 31: 178-89.
70. You Z, Savitz SI, Yang J, et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2008; 28: 1564-73.
71. Bermpohl D, You Z, Lo EH, et al. TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2007; 11: 1806-18.
72. Zhu S, Zhang Y, Bai G, Li H. Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease. Cell Death Disease. 2011; 2: e115; doi:.
73. Xu X, Chua K-W, Chua CC, et al. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res. 2010; 1355: 189-94.
74. Smith CCT, Davidson SM, Lim SY, et al. Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther. 2007; 21: 227-33.
75. Chua BHL, Gao J, Wang H, et al. Necrostatin-1 is a novel protector of myocardial infarction. Circulation. 2006; 114: II-212.
76. Lim SY, Davidson SM, Mocanu MM, et al. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial transition pore. Cardiovasc Drugs Ther. 2007; 21: 467-9.
77. Hausenloy DJ, Yellon M. Cardioprotective growth factors. Cadiovasc Res. 2009; 83: 179-94.
78. Rosenbaum DM, Degterev A, Joel D, et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res. 2010; 88: 1569-76.